<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Acta Naturae</journal-id><journal-title-group><journal-title xml:lang="en">Acta Naturae</journal-title><trans-title-group xml:lang="ru"><trans-title>Acta Naturae</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-8251</issn><publisher><publisher-name xml:lang="en">Acta Naturae Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">10627</article-id><article-id pub-id-type="doi">10.32607/20758251-2012-4-1-9-11</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Forum</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Форум</subject></subj-group><subj-group subj-group-type="article-type"><subject>Miscellaneous</subject></subj-group></article-categories><title-group><article-title xml:lang="en">V. Richter: "The low toxicity and originality of the pharmaceutical agent are its major advantages"</article-title><trans-title-group xml:lang="ru"><trans-title>В. А. Рихтер: «Преимущество препарата - низкая токсичность и оригинальность...»</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Richter</surname><given-names>V. A.</given-names></name><name xml:lang="ru"><surname>Рихтер</surname><given-names>В. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>actanaturae@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of Chemical Biology and Fundamental Medicine, SB RAS</institution></aff><aff><institution xml:lang="ru">Институт химической биологии и фундаментальной медицины СО РАН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2012-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2012</year></pub-date><volume>4</volume><issue>1</issue><issue-title xml:lang="en">VOL 4, NO1 (2012)</issue-title><issue-title xml:lang="ru">ТОМ 4, №1 (2012)</issue-title><fpage>9</fpage><lpage>11</lpage><history><date date-type="received" iso-8601-date="2020-01-17"><day>17</day><month>01</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2012, Richter V.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2012, Рихтер В.А.</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="en">Richter V.A.</copyright-holder><copyright-holder xml:lang="ru">Рихтер В.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://actanaturae.ru/2075-8251/article/view/10627">https://actanaturae.ru/2075-8251/article/view/10627</self-uri><abstract xml:lang="en"><p>There is no question that the government needs to provide vigorous financial support to Russian researchers looking to design new drugs. A different question is to what extent should the government participate in the financing and atwhat point should industrial investors join in?</p></abstract><trans-abstract xml:lang="ru"><p>Несомненно, для отечественных разработчиков новых препаратов необходима мощная финансовая поддержка со стороны государства. Другой вопрос, какова должна быть степень участия государства и в какой момент должны подключаться индустриальные инвесторы?</p></trans-abstract><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>www.nanoscopy.org/bionanoscopy/actanaturae.ru</mixed-citation></ref></ref-list></back></article>
